ClinicalTrials.gov
ClinicalTrials.gov Menu

Safety and Efficacy of EGEN-001 Combined With Carboplatin and Docetaxel in Recurrent, Platinum-Sensitive, Ovarian Cancer

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00473954
Recruitment Status : Completed
First Posted : May 16, 2007
Last Update Posted : March 26, 2013
Sponsor:
Information provided by (Responsible Party):
EGEN, Inc.

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Completed
  Actual Primary Completion Date : November 2009
  Actual Study Completion Date : November 2009